COMMUNIQUÉS West-GlobeNewswire

OraSure Technologies Earnings Conference Call Invitation
17/01/2018
2017 Fourth Quarter Earnings Conference Call Wednesday, February 7, 2018, 5:00 p.m. ET BETHLEHEM, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ) has scheduled its regular earnings [...]
MDxHealth: Shareholder Transparency Declaration
17/01/2018
NEWS RELEASE REGULATED INFORMATION INSIDE INFORMATION MDxHealth: Shareholder Transparency Declaration HERSTAL, BELGIUM and IRVINE, CA- January 17, 2018 - MDxHealth SA (Euronext: MDXH.BR) today announced that, that it [...]
MDxHealth: Déclaration de transparence d'un actionnaire
17/01/2018
COMMUNIQUE DE PRESSE INFORMATION REGLEMENTAIRE INFORMATION PRIVILIGIEE MDxHealth: Déclaration de transparence d'un actionnaire HERSTAL, BELGIUM and IRVINE, CA- Le 17 janvier, 2018 - MDxHealth SA (Euronext: MDXH.BR) a [...]
Novartis granted US FDA Priority Review for Kymriah(TM) (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL
17/01/2018
Filing acceptance marks second Priority Review granted to Kymriah by the FDA for two distinct indications, underscoring the potential of first ever FDA-approved CAR-T therapy EMA granted accelerated assessment to [...]
HalioDx closed a Series B round of €18.5 million (US$22.3 million)
17/01/2018
Press release janUARY 17, 2018 HalioDx closed a Series B round of €18.5 million (US$22.3 million) This funding will accelerate the development of Immunoscore® in selected cancers, and support set up of commercial [...]
HalioDx lève 18,5 millions d'euros dans un tour de Série B
17/01/2018
Communiqué de presse 17 janvier 2018 HalioDx lève 18,5 millions d'euros dans un tour de Série B Ce financement permettra à HalioDx d'accélérer le développement d'Immunoscore® dans différents cancers et d'accompagner son [...]
AzurRx BioPharma Receives $2 Million in Proceeds from Exercise of Warrants
17/01/2018
BROOKLYN, N.Y., Jan. 16, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
AveXis Announces Pricing of Public Offering of Common Stock
17/01/2018
CHICAGO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ) today announced the pricing of an underwritten public offering of 3,921,600 shares of its common stock at a public offering price of $102.00 per [...]
CORRECTION -- Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum
17/01/2018
SEATTLE, Jan. 16, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline on December 21, 2017 by Arzeda, we are advised by the company that "OP Fund" in the second paragraph should have read "OS Fund." The [...]
SENS Research Foundation 2017 Year End Fundraiser Achieves Over $5 Million in Donations
17/01/2018
MOUNTAIN VIEW, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- SENS Research Foundation (SRF), a leading Silicon Valley nonprofit focused on diseases of aging, announced today that it received over $5 Million in donations [...]
MediciNova to Present at the 98th Annual Meeting of the Chemical Society of Japan
17/01/2018
LA JOLLA, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Agilent Technologies Named 2017 Company of the Year by IBO
16/01/2018
LOS ANGELES, Jan. 16, 2018 (GLOBE NEWSWIRE) -- IBO today named Agilent Technologies (Santa Clara, CA) the 2017 Company of the Year. IBO is the leading newsletter tracking trends and developments in the analytical and [...]
BeiGene Announces Proposed Public Offering
16/01/2018
CAMBRIDGE, Mass. and BEIJING, China, Jan. 16, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
16/01/2018
RA’ANANA, Israel and NEW YORK, Jan. 16, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]
Golden Leaf Holdings Appoints Craig Eastwood as Chief Financial Officer
16/01/2018
TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced the [...]
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
16/01/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 16, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix [...]
HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock
16/01/2018
TUCSON, Ariz., Jan. 16, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced that it [...]
Obalon Therapeutics Announces Proposed Public Offering of Common Stock
16/01/2018
SAN DIEGO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Genocea Biosciences, Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Class A Warrants and Series A Convertible Preferred Stock and Class A Warrants
16/01/2018
CAMBRIDGE, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company that discovers and develops novel cancer vaccines, announced today that it intends to offer and [...]

Pages